Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Infectious Diseases and Mycology, and Cystic Fibrosis Research Advances.
The Role of β-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials.
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial.
Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease.
Efficacy and safety of brensocatib in Japanese patients with non-cystic fibrosis bronchiectasis: Analysis of the ASPEN trial.
Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
Pharmacodynamic assessment of apramycin against <i>Mycobacterium abscessus</i> in a hollow fibre infection model
Comprehensive Management Algorithm for <i>Mycobacterium avium</i> Complex Pulmonary Disease in the Real-World Setting.
Accuracy of VIDASⓇ TB-IGRA in TB patients and individuals with different thresholds of exposure
Chronic Pulmonary Aspergillosis and Nontuberculous Mycobacterial Pulmonary Disease: Two Peas in a Pod.
A systematic review of tetracyclines for nontuberculous mycobacteria: focus on rapidly growing mycobacteria.
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics.
Target regimen profiles for tuberculosis treatment
Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations
Genomic epidemiology of <i>Mycobacterium abscessus</i> at an adult cystic fibrosis programme reveals low potential for healthcare-associated transmission.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
Long-term Safety and Tolerability of Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Infections
Patient-Reported Symptom and Health-Related Quality-of-Life Validation and Responsiveness During the First 6 Months of Treatment for Mycobacterium avium Complex Pulmonary Disease.
Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis
Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis.
Transmission of <i>Mycobacterium avium</i> complex in healthcare settings: from environment, person to person, or both?
Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases
Management of Acute Distal Radioulnar Joint Instability Following a Distal Radius Fracture: A Systematic Review and Meta-Analysis
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
Airway Clearance Techniques in Bronchiectasis
Summary for Clinicians: 2020 Clinical Practice Guideline Summary for the Treatment of Nontuberculous Mycobacterial Pulmonary Disease
Management of Drug Toxicity in <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Expert Panel Survey
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study